These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18720192)

  • 1. Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.
    Bustanji Y; Taha MO; Almasri IM; Al-Ghussein MA; Mohammad MK; Alkhatib HS
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):771-8. PubMed ID: 18720192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.
    Mohammad MK; Al-Masri IM; Taha MO; Al-Ghussein MA; Alkhatib HS; Najjar S; Bustanji Y
    Eur J Pharmacol; 2008 Apr; 584(1):185-91. PubMed ID: 18295757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation.
    Mohammad M; Al-Masri IM; Issa A; Al-Ghussein MA; Fararjeh M; Alkhatib H; Taha MO; Bustanji Y
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):690-4. PubMed ID: 22512725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation.
    Motawi TM; Bustanji Y; El-Maraghy SA; Taha MO; Al Ghussein MA
    J Biochem Mol Toxicol; 2013 Sep; 27(9):425-36. PubMed ID: 23784744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
    Xiong Z; Hongmei Z; Lu S; Yu L
    Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of curcumin targets in neuroinflammatory pathways: molecular docking scores with GSK-3β, p38 MAPK, COX, ICE and TACE enzymes.
    Elumalai M; Muthaiah R; Alf MA
    Acta Pol Pharm; 2012; 69(2):237-45. PubMed ID: 22568037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
    Maqbool M; Mobashir M; Hoda N
    Eur J Med Chem; 2016 Jan; 107():63-81. PubMed ID: 26562543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
    Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
    Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
    Arfeen M; Patel R; Khan T; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.
    Bidon-Chanal A; Fuertes A; Alonso D; Pérez DI; Martínez A; Luque FJ; Medina M
    Eur J Med Chem; 2013 Feb; 60():479-89. PubMed ID: 23354070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.
    Khanfar MA; Asal BA; Mudit M; Kaddoumi A; El Sayed KA
    Bioorg Med Chem; 2009 Aug; 17(16):6032-9. PubMed ID: 19616957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation.
    Dugo L; Collin M; Thiemermann C
    Shock; 2007 Feb; 27(2):113-23. PubMed ID: 17224784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.
    Di Martino RM; De Simone A; Andrisano V; Bisignano P; Bisi A; Gobbi S; Rampa A; Fato R; Bergamini C; Perez DI; Martinez A; Bottegoni G; Cavalli A; Belluti F
    J Med Chem; 2016 Jan; 59(2):531-44. PubMed ID: 26696252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Zhang P; Hu HR; Bian SH; Huang ZH; Chu Y; Ye DY
    Eur J Med Chem; 2013 Mar; 61():95-103. PubMed ID: 23047001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate.
    Twomey C; McCarthy JV
    FEBS Lett; 2006 Jul; 580(17):4015-20. PubMed ID: 16814287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.